Investigation of the induction of antibodies against Crandell-Rees feline kidney cell lysates and feline renal cell lysates after parenteral administration of vaccines against feline viral rhinotracheitis, calicivirus, and panleukopenia in cats

Michael R. LappinDepartment of Clinical Sciences, Colorado State University, Fort Collins, CO 80523.
Department of Pathology, Colorado State University, Fort Collins, CO 80523.

Search for other papers by Michael R. Lappin in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Wayne A. JensenHeska Corp, 1613 Prospect Pkwy, Fort Collins, CO 80525.

Search for other papers by Wayne A. Jensen in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Tracey D. JensenWellington Veterinary Clinic PC, 3706 Cleveland Ave, Wellington, CO 80549.

Search for other papers by Tracey D. Jensen in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
Randall J. BasarabaDepartment of Pathology, Colorado State University, Fort Collins, CO 80523.

Search for other papers by Randall J. Basaraba in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Cathy A. BrownDepartment of Pathology, University of Georgia, Athens, GA 30602.

Search for other papers by Cathy A. Brown in
Current site
Google Scholar
PubMed
Close
 VMD, PhD
,
Steven V. RadeckiHeska Corp, 1613 Prospect Pkwy, Fort Collins, CO 80525.

Search for other papers by Steven V. Radecki in
Current site
Google Scholar
PubMed
Close
 PhD
, and
Jennifer R. HawleyDepartment of Clinical Sciences, Colorado State University, Fort Collins, CO 80523.
Department of Pathology, Colorado State University, Fort Collins, CO 80523.

Search for other papers by Jennifer R. Hawley in
Current site
Google Scholar
PubMed
Close
 BS
View More View Less

Abstract

Objective—To determine whether administration of Crandell-Rees feline kidney (CRFK) cell lysates or vaccines against feline viral rhinotracheitis, calicivirus, and panleukopenia (FVRCP vaccines) that likely contain CRFK cell proteins induces antibodies against CRFK cell or feline renal cell (FRC) lysates in cats.

Animals—14 eight-week-old cats.

Procedure—Before and after the study, renal biopsy specimens were obtained from each cat for histologic evaluation. Each of 4 FVRCP vaccines was administered to 2 cats at weeks 0, 3, 6, and 50. Between weeks 0 and 50, another 3 pairs of cats received 11 CRFK cell lysate inoculations SC (10, 50, or 50 µg mixed with alum). Clinicopathologic evaluations and ELISAs to detect serum antibodies against CRFK cell or FRC lysates were performed at intervals.

Results—Cats had no antibodies against CRFK cell or FRC lysates initially. All cats administered CRFK cell lysate had detectable antibodies against CRFK cell or FRC lysates on multiple occasions. Of 6 cats vaccinated parenterally, 5 had detectable antibodies against CRFK cell lysate at least once, but all 6 had detectable antibodies against FRC lysate on multiple occasions. Cats administered an intranasal-intraocular vaccine did not develop detectable antibodies against either lysate. Important clinicopathologic or histologic abnormalities were not detected during the study.

Conclusions and Clinical Relevance—Parenteral administration of vaccines containing viruses likely grown on CRFK cells induced antibodies against CRFK cell and FRC lysates in cats. Hypersensitization with CRFK cell proteins did not result in renal disease in cats during the 56-week study. (Am J Vet Res 2005;66:506–511)

Abstract

Objective—To determine whether administration of Crandell-Rees feline kidney (CRFK) cell lysates or vaccines against feline viral rhinotracheitis, calicivirus, and panleukopenia (FVRCP vaccines) that likely contain CRFK cell proteins induces antibodies against CRFK cell or feline renal cell (FRC) lysates in cats.

Animals—14 eight-week-old cats.

Procedure—Before and after the study, renal biopsy specimens were obtained from each cat for histologic evaluation. Each of 4 FVRCP vaccines was administered to 2 cats at weeks 0, 3, 6, and 50. Between weeks 0 and 50, another 3 pairs of cats received 11 CRFK cell lysate inoculations SC (10, 50, or 50 µg mixed with alum). Clinicopathologic evaluations and ELISAs to detect serum antibodies against CRFK cell or FRC lysates were performed at intervals.

Results—Cats had no antibodies against CRFK cell or FRC lysates initially. All cats administered CRFK cell lysate had detectable antibodies against CRFK cell or FRC lysates on multiple occasions. Of 6 cats vaccinated parenterally, 5 had detectable antibodies against CRFK cell lysate at least once, but all 6 had detectable antibodies against FRC lysate on multiple occasions. Cats administered an intranasal-intraocular vaccine did not develop detectable antibodies against either lysate. Important clinicopathologic or histologic abnormalities were not detected during the study.

Conclusions and Clinical Relevance—Parenteral administration of vaccines containing viruses likely grown on CRFK cells induced antibodies against CRFK cell and FRC lysates in cats. Hypersensitization with CRFK cell proteins did not result in renal disease in cats during the 56-week study. (Am J Vet Res 2005;66:506–511)

Advertisement